Inventor

EWING WILLIAM R

US87 patents

⚠️ This page may combine multiple inventors who share the name “EWING WILLIAM R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EWING WILLIAM R

BRISTOL MYERS SQUIBB CO

Pyrimidinones as factor XIa inhibitors

Bicyclic heterocycles as cannabinoid-1 receptor modulators

Azabicyclic heterocycles as cannabinoid receptor modulators

Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditions

Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions

Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions

Macrocycles as factor XIa inhibitors

Macrocycles as factor XIa inhibitors

Macrocycles as factor XIa inhibitors

N-sulfonylpiperidine cannabinoid receptor 1 antagonists

Tetrahydroquinoline derivatives as cannabinoid receptor modulators

Tetrahydroquinoline derivatives as cannabinoid receptor modulators

Azabicyclic heterocycles as cannabinoid receptor modulators

Compounds useful as motilin agonists and method

Heterocyclic aromatic compounds useful as growth hormone secretagogues

Pyrimidinones as factor XIA inhibitors

Pyrimidinones as factor XIa inhibitors

Macrocycles with aromatic P2′ groups as factor xia inhibitors

Dihydropyrazole GPR40 modulators

Substituted dihydropyrimidine inhibitors of calcium channel function

Pyrrolidine GPR40 modulators

Substituted glycine derived FXIA inhibitors

Pyrimidinones as factor XIA inhibitors

Factor XIa macrocycle inhibitors bearing a non-aromatic P2&#39; group

Heterocyclic aromatic compounds useful as growth hormone secretagogues

Azabicyclic heterocycles as cannabinoid receptor modulators

Bicyclic heterocycles as cannabinoid receptor modulators

Bicyclic heterocycles as cannabinoid receptor modulators

Dihydropyrazole GPR40 modulators

N-terminally modified GLP-1 receptor modulators

RHONE POULENC RORER PHARMA

Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds

Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds

Tetrahydro-pyrido-indoles as cholecystokinin and gastrin antagonists

Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds

Compounds having cholecystokinin and gastrin antagonistic properties

Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds

AVENTIS PHARMA GMBH

Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties

Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds

Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds

IVAC CORP

Apparatus and method for moving a tissue stress sensor for applanating an artery

UNIV PENNSYLVANIA

Substituted cyclodextrin sulfates and their uses as growth modulating agents

ALARIS MEDICAL SYST INC

Configuration control system for configuring multiple biomedical devices

PINTO DONALD J P

Macrocycles as factor XIa inhibitors

AVENTIS PHARMA INC

Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties

YU GUIXUE

Heterocyclic aromatic compounds useful as growth hormone secretagogues

SUN CHONGQING

Tetrahydroquinoline derivatives as cannabinoid receptor modulators

DISCOVERY PARTNERS INTERNAT

Card carrying an array of compounds

BRISTOL MYERS SQUIBB

Azabicyclic heterocycles as cannabinoid receptor modulators

ELLSWORTH BRUCE A

Pyrrolidine GPR40 modulators

EWING WILLIAM R

Heterocyclic aromatic compounds useful as growth hormone secretagogues

Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group